EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Updates on the Treatment and Management of Large Vessel Vasculitis

Stephanie Garner,

Canadian Rheumatology Today · 10.07.2026 · 27-34

DOI: 10.58931/crt.2026.3172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Rheumatology Today, online erschienen am 10.07.2026. Verfasst von Stephanie Garner,. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Large vessel vasculitis (LVV), encompassing giant cell arteritis (GCA) and Takayasu arteritis (TAK), causes granulomatous inflammation of large- and medium-sized arteries with potentially devastating ischemic complications. Glucocorticoids remain first-line therapy but carry significant long‑term morbidity.

Methods

This narrative review synthesizes current evidence on the classification, diagnosis, monitoring, and management of LVV, incorporating data from randomized controlled trials, meta‑analyses, and international guidelines.

Results

Advances in vascular imaging have improved diagnostic accuracy and increasingly supplement or replace temporal artery biopsy. In GCA, phase 3 trials have demonstrated that tocilizumab and upadacitinib have superior remission rates and glucocorticoid-sparing effects. In TAK, tumour necrosis factor inhibitors remain the preferred biologic for refractory disease, with emerging evidence supporting Janus kinase (JAK) inhibition and novel disease-modifying anti-rheumatic drug combinations.

Conclusion

Targeted therapies have transformed LVV management, though reliable biomarkers for disease activity and consensus on optimal treatment duration remain unmet needs. Keywords: large vessel vasculitis, giant cell arteritis, Takayasu arteritis, tocilizumab, upadacitinib, glucocorticoid-sparing, JAK inhibitors

Zitieren

APA

Garner,, S. (2026). Updates on the Treatment and Management of Large Vessel Vasculitis. Canadian Rheumatology Today, 27-34. https://doi.org/10.58931/crt.2026.3172

Vancouver

Garner, S. Updates on the Treatment and Management of Large Vessel Vasculitis. Canadian Rheumatology Today. 2026:27-34. doi:10.58931/crt.2026.3172

BibTeX
@article{Garner2026,
  author = {Garner,, Stephanie},
  title = {Updates on the Treatment and Management of Large Vessel Vasculitis},
  journal = {Canadian Rheumatology Today},
  year = {2026},
  pages = {27--34},
  doi = {10.58931/crt.2026.3172}
}
Kostenlos starten →